• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受院内心肺复苏的 IV 期癌症患者的结局:一项基于人群的队列研究。

Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study.

机构信息

Department of Internal Medicine, National Taiwan University Hospital, Hsin-Chu Branch, Hsin-Chu, Taiwan.

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Sci Rep. 2019 Jul 1;9(1):9478. doi: 10.1038/s41598-019-45977-4.

DOI:10.1038/s41598-019-45977-4
PMID:31263137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6602946/
Abstract

The effects of cardiopulmonary resuscitation (CPR) on patients with advanced cancer remain to be elucidated. We identified a cohort of patients with stage-IV cancer who received in-hospital CPR from the Taiwan Cancer Registry and National Health Insurance claims database, along with a matched cohort without cancer who also received in-hospital CPR. The main outcomes were post-discharge survival and in-hospital mortality. In total, 3,446 stage-IV cancer patients who underwent in-hospital CPR after cancer diagnosis were identified during January 2009-June 2014. A vast majority of the patients did not survive to discharge (n = 2,854, 82.8%). The median post-discharge survival was 22 days; 10.1% (n = 60; 1.7% of all patients) of the hospital survivors received anticancer therapy after discharge. We created 1:1 age-, sex-, Charlson comorbidity index (CCI)-, and year of CPR-matched noncancer and stage-IV cancer cohorts (n = 3,425 in both; in-hospital mortality rate = 82.1% and 82.8%, respectively). Regression analysis showed that the stage-IV cancer cohort had shorter post-discharge survival than did the noncancer cohort. The outcome of patients with advanced cancer was poor. Even among the survivors, post-discharge survival was short, with only few patients receiving further anticancer therapy.

摘要

心肺复苏术(CPR)对晚期癌症患者的影响仍有待阐明。我们从台湾癌症登记处和全民健康保险理赔数据库中确定了一组在医院接受 CPR 的 IV 期癌症患者,以及一组没有癌症但也在医院接受 CPR 的匹配队列。主要结果是出院后生存和院内死亡率。总共确定了 3446 名在癌症诊断后接受院内 CPR 的 IV 期癌症患者,这些患者在 2009 年 1 月至 2014 年 6 月期间接受了治疗。绝大多数患者未存活至出院(n=2854,82.8%)。出院后的中位生存时间为 22 天;出院后有 10.1%(n=60;占所有患者的 1.7%)的医院幸存者接受了抗癌治疗。我们创建了 1:1 的年龄、性别、Charlson 合并症指数(CCI)和 CPR 匹配的非癌症和 IV 期癌症队列(每组 n=3425;院内死亡率分别为 82.1%和 82.8%)。回归分析表明,IV 期癌症队列的出院后生存时间短于非癌症队列。晚期癌症患者的预后较差。即使在幸存者中,出院后的生存时间也很短,只有少数患者接受了进一步的抗癌治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd88/6602946/b68ae1d87f01/41598_2019_45977_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd88/6602946/6a35173f7181/41598_2019_45977_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd88/6602946/b68ae1d87f01/41598_2019_45977_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd88/6602946/6a35173f7181/41598_2019_45977_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd88/6602946/b68ae1d87f01/41598_2019_45977_Fig2_HTML.jpg

相似文献

1
Outcome of stage IV cancer patients receiving in-hospital cardiopulmonary resuscitation: a population-based cohort study.接受院内心肺复苏的 IV 期癌症患者的结局:一项基于人群的队列研究。
Sci Rep. 2019 Jul 1;9(1):9478. doi: 10.1038/s41598-019-45977-4.
2
Long-Term Outcomes in Critically Ill Septic Patients Who Survived Cardiopulmonary Resuscitation.心肺复苏成功的重症脓毒症患者的长期预后
Crit Care Med. 2016 Jun;44(6):1067-74. doi: 10.1097/CCM.0000000000001608.
3
Predictors Associated with Survival Among Elderly In-Patients Who Receive Cardiopulmonary Resuscitation in Japan: An Observational Cohort Study.日本接受心肺复苏的老年住院患者生存相关预测因素:一项观察性队列研究。
J Gen Intern Med. 2019 Feb;34(2):206-210. doi: 10.1007/s11606-018-4747-5. Epub 2018 Nov 27.
4
Outcomes of in-hospital cardiopulmonary resuscitation for patients with end-stage liver disease.终末期肝病患者院内心肺复苏的结局。
Liver Int. 2019 Jul;39(7):1256-1262. doi: 10.1111/liv.14079. Epub 2019 Mar 26.
5
Trends in in-hospital cardiopulmonary resuscitation and survival in adults receiving maintenance dialysis.接受维持性透析的成人患者院内心肺复苏及生存趋势
JAMA Intern Med. 2015 Jun;175(6):1028-35. doi: 10.1001/jamainternmed.2015.0406.
6
Epidemiology and outcomes of in-hospital cardiopulmonary resuscitation in the United States, 2000-2009.2000-2009 年美国院内心肺复苏的流行病学和结局。
Resuscitation. 2013 Sep;84(9):1255-60. doi: 10.1016/j.resuscitation.2013.02.021. Epub 2013 Mar 5.
7
Survival and functional outcomes after cardiopulmonary resuscitation in the intensive care unit.心肺复苏术后在重症监护病房的生存和功能结果。
J Crit Care. 2012 Aug;27(4):421.e9-17. doi: 10.1016/j.jcrc.2011.11.001. Epub 2012 Jan 9.
8
Impact of cardiopulmonary resuscitation duration on survival from paramedic witnessed out-of-hospital cardiac arrests: An observational study.急救员目击院外心脏骤停患者心肺复苏持续时间对生存率的影响:一项观察性研究。
Resuscitation. 2016 Mar;100:25-31. doi: 10.1016/j.resuscitation.2015.12.011. Epub 2016 Jan 13.
9
ROSC rates and live discharge rates after cardiopulmonary resuscitation by different CPR teams - a retrospective cohort study.不同心肺复苏团队进行心肺复苏后的自主循环恢复率和存活出院率——一项回顾性队列研究
BMC Anesthesiol. 2017 Dec 4;17(1):166. doi: 10.1186/s12871-017-0457-5.
10
Outcomes of In-Hospital Cardiopulmonary Resuscitation Among Patients With Cancer.癌症患者院内心肺复苏的结局
Am J Hosp Palliat Care. 2017 Apr;34(3):212-216. doi: 10.1177/1049909115617934. Epub 2016 Jul 10.

引用本文的文献

1
[Changes in treatment goals and palliative care in the intensive care unit-when and how?].[重症监护病房治疗目标与姑息治疗的变化——何时以及如何变化?]
Med Klin Intensivmed Notfmed. 2025 Sep 2. doi: 10.1007/s00063-025-01324-2.
2
Lipid Levels and Lung Cancer Risk: Findings from the Taiwan National Data Systems from 2012 to 2018.血脂水平与肺癌风险:2012年至2018年台湾国家数据系统的研究结果
J Epidemiol Glob Health. 2025 Jan 30;15(1):11. doi: 10.1007/s44197-025-00351-8.
3
Racial disparities in the frequency and timing of code status orders among women with breast cancer.

本文引用的文献

1
In-Hospital Cardiac Arrest: A Review.院内心搏骤停:综述。
JAMA. 2019 Mar 26;321(12):1200-1210. doi: 10.1001/jama.2019.1696.
2
Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.真实世界中 EGFR 突变阳性非小细胞肺癌的治疗和结局:大型患者队列的长期随访。
Lung Cancer. 2018 Mar;117:14-19. doi: 10.1016/j.lungcan.2018.01.005. Epub 2018 Jan 9.
3
Systemic Treatment of Patients with Advanced, Unresectable Hepatocellular Carcinoma: Emergence of Therapies.
乳腺癌女性患者的医嘱频度和时机存在种族差异。
BMC Cancer. 2024 Nov 19;24(1):1426. doi: 10.1186/s12885-024-13132-6.
4
Impact of isoniazid monoresistance on overall and vulnerable patient populations in Taiwan.台湾地区异烟肼单耐药对全人群和脆弱人群的影响。
Emerg Microbes Infect. 2024 Dec;13(1):2417855. doi: 10.1080/22221751.2024.2417855. Epub 2024 Oct 23.
5
Factors affecting do-not-attempt-resuscitation (DNAR) decisions among adult patients in the emergency department of a general tertiary teaching hospital in China: a retrospective observational study.中国一家综合性三级教学医院急诊科成人患者不进行心肺复苏术(DNAR)决策的影响因素:一项回顾性观察研究。
BMJ Open. 2023 Oct 10;13(10):e075714. doi: 10.1136/bmjopen-2023-075714.
6
Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.口服替加氟尿嘧啶与静脉化疗作为可切除的早期非小细胞肺癌患者的辅助治疗。
Cancer Med. 2023 Sep;12(17):17993-18004. doi: 10.1002/cam4.6440. Epub 2023 Aug 9.
7
Impact of Race on Outcomes of Advanced Stage Non-Small Cell Lung Cancer Patients Receiving Immunotherapy.种族对接受免疫治疗的晚期非小细胞肺癌患者结局的影响。
Curr Oncol. 2023 Apr 18;30(4):4208-4221. doi: 10.3390/curroncol30040321.
8
Indicators of Clinical Trajectory in Patients With Cancer Who Receive Cardiopulmonary Resuscitation.接受心肺复苏的癌症患者临床转归的指标。
J Natl Compr Canc Netw. 2023 Jan;21(1):51-59.e10. doi: 10.6004/jnccn.2022.7072.
9
Factors influencing terminal cancer patients' autonomous DNR decision: a longitudinal statutory document and clinical database study.影响终末期癌症患者自主 DNR 决策的因素:一项纵向法定文件和临床数据库研究。
BMC Palliat Care. 2022 Aug 27;21(1):149. doi: 10.1186/s12904-022-01037-9.
10
Trends in In-Hospital Cardiopulmonary Resuscitation from 2010 through 2019: A Nationwide Cohort Study in South Korea.2010年至2019年韩国院内心肺复苏趋势:一项全国性队列研究
J Pers Med. 2022 Mar 1;12(3):377. doi: 10.3390/jpm12030377.
晚期不可切除肝细胞癌患者的系统治疗:治疗方法的出现
J Gastrointest Cancer. 2018 Jun;49(2):107-115. doi: 10.1007/s12029-018-0065-8.
4
Acute biliary events during anti-tuberculosis treatment: hospital case series and a nationwide cohort study.抗结核治疗期间的急性胆道事件:医院病例系列研究及全国队列研究
BMC Infect Dis. 2018 Feb 1;18(1):64. doi: 10.1186/s12879-018-2966-3.
5
Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan.在中负担环境下开展结核接触者调查:来自台湾大型结核接触者队列的启示。
Eur Respir J. 2017 Aug 24;50(2). doi: 10.1183/13993003.00851-2017. Print 2017 Aug.
6
Patterns of Resuscitation Care and Survival After In-Hospital Cardiac Arrest in Patients With Advanced Cancer.晚期癌症患者院内心脏骤停后的复苏护理模式与生存情况
J Oncol Pract. 2017 Oct;13(10):e821-e830. doi: 10.1200/JOP.2016.020404. Epub 2017 Aug 1.
7
Terminally Ill Taiwanese Cancer Patients' and Family Caregivers' Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional Studies.晚期台湾癌症患者及其家庭照顾者在维持生命治疗偏好模式上的一致性较差且在十年间呈下降趋势:两项独立横断面研究的结果
J Pain Symptom Manage. 2017 Jul;54(1):35-45.e4. doi: 10.1016/j.jpainsymman.2017.02.013. Epub 2017 Apr 24.
8
Do-not-resuscitate orders in cancer patients: a review of literature.癌症患者的“不要复苏”医嘱:文献综述
Support Care Cancer. 2017 Feb;25(2):677-685. doi: 10.1007/s00520-016-3459-9. Epub 2016 Oct 22.
9
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer.患者签署的“不要复苏”同意书表明晚期癌症患者的临终关怀质量更佳。
Support Care Cancer. 2017 Feb;25(2):533-539. doi: 10.1007/s00520-016-3434-5. Epub 2016 Oct 4.
10
Lung cancer: current therapies and new targeted treatments.肺癌:当前疗法与新的靶向治疗。
Lancet. 2017 Jan 21;389(10066):299-311. doi: 10.1016/S0140-6736(16)30958-8. Epub 2016 Aug 27.